Van Doninck, Eline https://orcid.org/0009-0003-7454-0026
De Keersmaecker, Anna-Victoria
D’hooghe, Marie
Van Wijmeersch, Bart
Perrotta, Gaetano
El Sankari, Souraya
van Pesch, Vincent
Dive, Dominique
D’Haeseleer, Miguel
Laureys, Guy
Willekens, Barbara
Willem, Lander
Popescu, Veronica
,
Funding for this research was provided by:
FWO-TBM (T001121N)
FWO-TBM (T001121N)
FWO-TBM (T001121N)
FWO-TBM (T001121N)
Novartis Belgium
Article History
Received: 4 June 2025
Accepted: 14 October 2025
First Online: 3 November 2025
Declarations
:
: AD received conference travel support from Biogen and research funding from Belgian Charcot Foundation. BV has received speaker/advisor fees, research support and travel grants: Almirall, Actelion/Janssen, Bayer, Biogen, Celgene/BMS, Imcyse, Merck, Novartis, Roche and Sanofi Genzyme. VV has received travel grants from Merck Healthcare KGaA (Darmstadt, Germany), Biogen, Sanofi, Bristol Meyer Squibb, Almirall and Roche. His institution has received research grants and consultancy fees from Roche, Biogen, Sanofi, Merck Healthcare KGaA (Darmstadt, Germany), Bristol Meyer Squibb, Janssen, Almirall, Alexion and Novartis Pharma. BW received honoraria for acting as a member of Scientific Advisory Boards/Consultancy for Almirall, Biogen, Celgene/BMS, Merck, Janssen, Novartis, Roche, Sandoz, Sanofi-Genzyme and speaker honoraria and travel support from Biogen, Celgene/BMS, Merck, Novartis, Roche, SanofiGenzyme; research and/or patient support grants from Biogen, Janssen, Merck, Sanofi-Genzyme, Roche. Honoraria and grants were paid to UZA/UZA Foundation. Further, BW received research funding from FWO-TBM, Belgian Charcot Foundation, Start2Cure Foundation, Queen Elisabeth Medical Foundation for Neurosciences and the National MS Society USA. VP has received honoraria and travel and research grants from Almirall, Biogen, Medtronic, Merck, Novartis, Roche, Sanofi-Genzyme and Teva Pharmaceuticals. EV, MDh, MDH, GP, SES, DD, GL and LW have nothing to declare.